Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry
- Autores
- Stancampiano, Marianna R.; Lucas-Herald, Angela K.; Bryce, Jillian; Russo, Gianni; Barera, Graziano; Balsamo, Antonio; Baronio, Federico; Bertelloni, Silvano; Valiani, Margherita; Cools, Martine; Tack, Lloyd J.W.; Darendeliler, Feyza; Poyrazoglu, Sukran; Globa, Evgenia; Grinspon, Romina; Hannema, Sabine E.; Hughes, Ieuan A.; Tadokoro Cuccaro, Rieko; Thankamony, Ajay; Iotova, Violeta; Mladenov, Vilhelm; Konrad, Daniel; Mazen, Inas; Niedziela, Marek; Kolesinska, Zofia; Nordenström, Anna; Ahmed, S. Faisal
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- It is unclear whether testosterone replacement therapy (TRT) in adolescent boys, affected by a range of endocrine diseases that may be associated with hypogonadism, is particularly common. The aim of this study was to assess the contemporary practice of TRT in boys included in the I-DSD Registry. All participating centres in the I-DSD Registry that had boys between 10 and 18 years of age and with a condition that could be associated with hypogonadism were invited to provide further information in 2019. Information on 162 boys was collected from 15 centres that had a median (range) number of 6 boys per centre (1.35). Of these, 30 (19%) from 9 centres were receiving TRT and the median (range) age at the start was 12.6 years (10.8-16.2), with 6 boys (20%) starting at <12 years. Median (range) age of boys not on TRT was 11.7 years (10.7-17.7), and 69 out of 132 (52%) were <12 years. TRT had been initiated in 20 of 71 (28%) boys with a disorder of gonadal development, 3 of 14 (21%) with a disorder of androgen synthesis, and all 7 (100%) boys with hypogonadotropic hypogonadism. The remainder who did not have TRT included 15 boys with partial androgen insensitivity, 52 with non-specific XY DSD, and 3 with persistent Müllerian duct syndrome. Before starting TRT, liver function and blood count were checked in 19 (68%) and 18 boys (64%), respectively, a bone age assessment was performed in 23 (82%) and bone mineral density assessment in 12 boys (43%). This snapshot of contemporary practice reveals that TRT in boys included in the I-DSD Registry is not very common, whilst the variation in starting and monitoring therapy is quite marked. Standardisation of practice may lead to more effective assessment of treatment outcomes.
Fil: Stancampiano, Marianna R.. University of Glasgow; Reino Unido
Fil: Lucas-Herald, Angela K.. University of Glasgow; Reino Unido
Fil: Bryce, Jillian. University of Glasgow; Reino Unido
Fil: Russo, Gianni. No especifíca;
Fil: Barera, Graziano. No especifíca;
Fil: Balsamo, Antonio. No especifíca;
Fil: Baronio, Federico. No especifíca;
Fil: Bertelloni, Silvano. No especifíca;
Fil: Valiani, Margherita. No especifíca;
Fil: Cools, Martine. No especifíca;
Fil: Tack, Lloyd J.W.. No especifíca;
Fil: Darendeliler, Feyza. No especifíca;
Fil: Poyrazoglu, Sukran. No especifíca;
Fil: Globa, Evgenia. No especifíca;
Fil: Grinspon, Romina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina
Fil: Hannema, Sabine E.. No especifíca;
Fil: Hughes, Ieuan A.. University of Cambridge; Estados Unidos
Fil: Tadokoro Cuccaro, Rieko. University of Cambridge; Estados Unidos
Fil: Thankamony, Ajay. University of Cambridge; Estados Unidos
Fil: Iotova, Violeta. No especifíca;
Fil: Mladenov, Vilhelm. No especifíca;
Fil: Konrad, Daniel. No especifíca;
Fil: Mazen, Inas. No especifíca;
Fil: Niedziela, Marek. No especifíca;
Fil: Kolesinska, Zofia. No especifíca;
Fil: Nordenström, Anna. No especifíca;
Fil: Ahmed, S. Faisal. University of Glasgow; Reino Unido - Materia
-
ADOLESCENT BOYS
DSD
HYPOGONADISM
TESTOSTERONE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/172108
Ver los metadatos del registro completo
id |
CONICETDig_121705407c0a7a65f64e234d89205a06 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/172108 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD RegistryStancampiano, Marianna R.Lucas-Herald, Angela K.Bryce, JillianRusso, GianniBarera, GrazianoBalsamo, AntonioBaronio, FedericoBertelloni, SilvanoValiani, MargheritaCools, MartineTack, Lloyd J.W.Darendeliler, FeyzaPoyrazoglu, SukranGloba, EvgeniaGrinspon, RominaHannema, Sabine E.Hughes, Ieuan A.Tadokoro Cuccaro, RiekoThankamony, AjayIotova, VioletaMladenov, VilhelmKonrad, DanielMazen, InasNiedziela, MarekKolesinska, ZofiaNordenström, AnnaAhmed, S. FaisalADOLESCENT BOYSDSDHYPOGONADISMTESTOSTERONEhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3It is unclear whether testosterone replacement therapy (TRT) in adolescent boys, affected by a range of endocrine diseases that may be associated with hypogonadism, is particularly common. The aim of this study was to assess the contemporary practice of TRT in boys included in the I-DSD Registry. All participating centres in the I-DSD Registry that had boys between 10 and 18 years of age and with a condition that could be associated with hypogonadism were invited to provide further information in 2019. Information on 162 boys was collected from 15 centres that had a median (range) number of 6 boys per centre (1.35). Of these, 30 (19%) from 9 centres were receiving TRT and the median (range) age at the start was 12.6 years (10.8-16.2), with 6 boys (20%) starting at <12 years. Median (range) age of boys not on TRT was 11.7 years (10.7-17.7), and 69 out of 132 (52%) were <12 years. TRT had been initiated in 20 of 71 (28%) boys with a disorder of gonadal development, 3 of 14 (21%) with a disorder of androgen synthesis, and all 7 (100%) boys with hypogonadotropic hypogonadism. The remainder who did not have TRT included 15 boys with partial androgen insensitivity, 52 with non-specific XY DSD, and 3 with persistent Müllerian duct syndrome. Before starting TRT, liver function and blood count were checked in 19 (68%) and 18 boys (64%), respectively, a bone age assessment was performed in 23 (82%) and bone mineral density assessment in 12 boys (43%). This snapshot of contemporary practice reveals that TRT in boys included in the I-DSD Registry is not very common, whilst the variation in starting and monitoring therapy is quite marked. Standardisation of practice may lead to more effective assessment of treatment outcomes.Fil: Stancampiano, Marianna R.. University of Glasgow; Reino UnidoFil: Lucas-Herald, Angela K.. University of Glasgow; Reino UnidoFil: Bryce, Jillian. University of Glasgow; Reino UnidoFil: Russo, Gianni. No especifíca;Fil: Barera, Graziano. No especifíca;Fil: Balsamo, Antonio. No especifíca;Fil: Baronio, Federico. No especifíca;Fil: Bertelloni, Silvano. No especifíca;Fil: Valiani, Margherita. No especifíca;Fil: Cools, Martine. No especifíca;Fil: Tack, Lloyd J.W.. No especifíca;Fil: Darendeliler, Feyza. No especifíca;Fil: Poyrazoglu, Sukran. No especifíca;Fil: Globa, Evgenia. No especifíca;Fil: Grinspon, Romina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Hannema, Sabine E.. No especifíca;Fil: Hughes, Ieuan A.. University of Cambridge; Estados UnidosFil: Tadokoro Cuccaro, Rieko. University of Cambridge; Estados UnidosFil: Thankamony, Ajay. University of Cambridge; Estados UnidosFil: Iotova, Violeta. No especifíca;Fil: Mladenov, Vilhelm. No especifíca;Fil: Konrad, Daniel. No especifíca;Fil: Mazen, Inas. No especifíca;Fil: Niedziela, Marek. No especifíca;Fil: Kolesinska, Zofia. No especifíca;Fil: Nordenström, Anna. No especifíca;Fil: Ahmed, S. Faisal. University of Glasgow; Reino UnidoKarger2021-07-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/172108Stancampiano, Marianna R.; Lucas-Herald, Angela K.; Bryce, Jillian; Russo, Gianni; Barera, Graziano; et al.; Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry; Karger; Sexual Development; 15; 4; 7-7-2021; 236-2431661-5425CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1159/000516784info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:55:23Zoai:ri.conicet.gov.ar:11336/172108instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:55:23.848CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry |
title |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry |
spellingShingle |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry Stancampiano, Marianna R. ADOLESCENT BOYS DSD HYPOGONADISM TESTOSTERONE |
title_short |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry |
title_full |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry |
title_fullStr |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry |
title_full_unstemmed |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry |
title_sort |
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry |
dc.creator.none.fl_str_mv |
Stancampiano, Marianna R. Lucas-Herald, Angela K. Bryce, Jillian Russo, Gianni Barera, Graziano Balsamo, Antonio Baronio, Federico Bertelloni, Silvano Valiani, Margherita Cools, Martine Tack, Lloyd J.W. Darendeliler, Feyza Poyrazoglu, Sukran Globa, Evgenia Grinspon, Romina Hannema, Sabine E. Hughes, Ieuan A. Tadokoro Cuccaro, Rieko Thankamony, Ajay Iotova, Violeta Mladenov, Vilhelm Konrad, Daniel Mazen, Inas Niedziela, Marek Kolesinska, Zofia Nordenström, Anna Ahmed, S. Faisal |
author |
Stancampiano, Marianna R. |
author_facet |
Stancampiano, Marianna R. Lucas-Herald, Angela K. Bryce, Jillian Russo, Gianni Barera, Graziano Balsamo, Antonio Baronio, Federico Bertelloni, Silvano Valiani, Margherita Cools, Martine Tack, Lloyd J.W. Darendeliler, Feyza Poyrazoglu, Sukran Globa, Evgenia Grinspon, Romina Hannema, Sabine E. Hughes, Ieuan A. Tadokoro Cuccaro, Rieko Thankamony, Ajay Iotova, Violeta Mladenov, Vilhelm Konrad, Daniel Mazen, Inas Niedziela, Marek Kolesinska, Zofia Nordenström, Anna Ahmed, S. Faisal |
author_role |
author |
author2 |
Lucas-Herald, Angela K. Bryce, Jillian Russo, Gianni Barera, Graziano Balsamo, Antonio Baronio, Federico Bertelloni, Silvano Valiani, Margherita Cools, Martine Tack, Lloyd J.W. Darendeliler, Feyza Poyrazoglu, Sukran Globa, Evgenia Grinspon, Romina Hannema, Sabine E. Hughes, Ieuan A. Tadokoro Cuccaro, Rieko Thankamony, Ajay Iotova, Violeta Mladenov, Vilhelm Konrad, Daniel Mazen, Inas Niedziela, Marek Kolesinska, Zofia Nordenström, Anna Ahmed, S. Faisal |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
ADOLESCENT BOYS DSD HYPOGONADISM TESTOSTERONE |
topic |
ADOLESCENT BOYS DSD HYPOGONADISM TESTOSTERONE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
It is unclear whether testosterone replacement therapy (TRT) in adolescent boys, affected by a range of endocrine diseases that may be associated with hypogonadism, is particularly common. The aim of this study was to assess the contemporary practice of TRT in boys included in the I-DSD Registry. All participating centres in the I-DSD Registry that had boys between 10 and 18 years of age and with a condition that could be associated with hypogonadism were invited to provide further information in 2019. Information on 162 boys was collected from 15 centres that had a median (range) number of 6 boys per centre (1.35). Of these, 30 (19%) from 9 centres were receiving TRT and the median (range) age at the start was 12.6 years (10.8-16.2), with 6 boys (20%) starting at <12 years. Median (range) age of boys not on TRT was 11.7 years (10.7-17.7), and 69 out of 132 (52%) were <12 years. TRT had been initiated in 20 of 71 (28%) boys with a disorder of gonadal development, 3 of 14 (21%) with a disorder of androgen synthesis, and all 7 (100%) boys with hypogonadotropic hypogonadism. The remainder who did not have TRT included 15 boys with partial androgen insensitivity, 52 with non-specific XY DSD, and 3 with persistent Müllerian duct syndrome. Before starting TRT, liver function and blood count were checked in 19 (68%) and 18 boys (64%), respectively, a bone age assessment was performed in 23 (82%) and bone mineral density assessment in 12 boys (43%). This snapshot of contemporary practice reveals that TRT in boys included in the I-DSD Registry is not very common, whilst the variation in starting and monitoring therapy is quite marked. Standardisation of practice may lead to more effective assessment of treatment outcomes. Fil: Stancampiano, Marianna R.. University of Glasgow; Reino Unido Fil: Lucas-Herald, Angela K.. University of Glasgow; Reino Unido Fil: Bryce, Jillian. University of Glasgow; Reino Unido Fil: Russo, Gianni. No especifíca; Fil: Barera, Graziano. No especifíca; Fil: Balsamo, Antonio. No especifíca; Fil: Baronio, Federico. No especifíca; Fil: Bertelloni, Silvano. No especifíca; Fil: Valiani, Margherita. No especifíca; Fil: Cools, Martine. No especifíca; Fil: Tack, Lloyd J.W.. No especifíca; Fil: Darendeliler, Feyza. No especifíca; Fil: Poyrazoglu, Sukran. No especifíca; Fil: Globa, Evgenia. No especifíca; Fil: Grinspon, Romina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina Fil: Hannema, Sabine E.. No especifíca; Fil: Hughes, Ieuan A.. University of Cambridge; Estados Unidos Fil: Tadokoro Cuccaro, Rieko. University of Cambridge; Estados Unidos Fil: Thankamony, Ajay. University of Cambridge; Estados Unidos Fil: Iotova, Violeta. No especifíca; Fil: Mladenov, Vilhelm. No especifíca; Fil: Konrad, Daniel. No especifíca; Fil: Mazen, Inas. No especifíca; Fil: Niedziela, Marek. No especifíca; Fil: Kolesinska, Zofia. No especifíca; Fil: Nordenström, Anna. No especifíca; Fil: Ahmed, S. Faisal. University of Glasgow; Reino Unido |
description |
It is unclear whether testosterone replacement therapy (TRT) in adolescent boys, affected by a range of endocrine diseases that may be associated with hypogonadism, is particularly common. The aim of this study was to assess the contemporary practice of TRT in boys included in the I-DSD Registry. All participating centres in the I-DSD Registry that had boys between 10 and 18 years of age and with a condition that could be associated with hypogonadism were invited to provide further information in 2019. Information on 162 boys was collected from 15 centres that had a median (range) number of 6 boys per centre (1.35). Of these, 30 (19%) from 9 centres were receiving TRT and the median (range) age at the start was 12.6 years (10.8-16.2), with 6 boys (20%) starting at <12 years. Median (range) age of boys not on TRT was 11.7 years (10.7-17.7), and 69 out of 132 (52%) were <12 years. TRT had been initiated in 20 of 71 (28%) boys with a disorder of gonadal development, 3 of 14 (21%) with a disorder of androgen synthesis, and all 7 (100%) boys with hypogonadotropic hypogonadism. The remainder who did not have TRT included 15 boys with partial androgen insensitivity, 52 with non-specific XY DSD, and 3 with persistent Müllerian duct syndrome. Before starting TRT, liver function and blood count were checked in 19 (68%) and 18 boys (64%), respectively, a bone age assessment was performed in 23 (82%) and bone mineral density assessment in 12 boys (43%). This snapshot of contemporary practice reveals that TRT in boys included in the I-DSD Registry is not very common, whilst the variation in starting and monitoring therapy is quite marked. Standardisation of practice may lead to more effective assessment of treatment outcomes. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-07-07 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/172108 Stancampiano, Marianna R.; Lucas-Herald, Angela K.; Bryce, Jillian; Russo, Gianni; Barera, Graziano; et al.; Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry; Karger; Sexual Development; 15; 4; 7-7-2021; 236-243 1661-5425 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/172108 |
identifier_str_mv |
Stancampiano, Marianna R.; Lucas-Herald, Angela K.; Bryce, Jillian; Russo, Gianni; Barera, Graziano; et al.; Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD Registry; Karger; Sexual Development; 15; 4; 7-7-2021; 236-243 1661-5425 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1159/000516784 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Karger |
publisher.none.fl_str_mv |
Karger |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269342054481920 |
score |
13.13397 |